L’Institut Mérieux has sold its subsidiary ABL Lyon (renamed to Active Biomarkers) to Turenne Santé
Paris – CFI France is pleased to announce that they acted as exclusive financial advisor to l’Institut Mérieux in the sale of its subsidiary ABL Lyon (renamed to Active Biomarkers) to Turenne Santé.
L’Institut Merieux was founded in 1897 in Lyon, is a family holding company dedicated to global public health around the world.
ABL Lyon, now renamed Active Biomarkers, is an integrated bioanalytical laboratory with biomarker and cell-based assay testing capabilities, specialized in well-targeted therapeutic fields such as oncology, infectious diseases, inflammatory pathologies and neurodegenerative diseases.
The company supports multiple biopharmaceutical companies in their clinical research programs (Phases I to IV).
With the support of Turenne Santé, Active Biomarkers will pursue its dynamic growth by gaining new customers. It will also enable to boost significantly its production and R&D capacity, to strengthen its portfolio of proprietary assays, and to evaluate external growth opportunities.
The transaction was announced on 5 November 2020.
Our latest transactions
Real Estate & Construction
has been acquired by
Transaction details
Blue Bay Building Products has been acquired by Wolseley Group, a leading specialist provider of plumbing, heating, cooling, and utility products to trade customers
Food & Beverage & Agribusiness
has sold
to
Transaction details
Fleury Michon has sold Room Saveurs, a trading company and laboratory specialized in the development of meal trays, to Kumo
Industrials
has transferred the equity interests of its subsidiary
to
Transaction details
Maezawa Kyuso Industries has transferred the equity interests of Maezawa Kyuso (Nanchang) to Guangzhou Hongxing Investment Co., Ltd.
Software & IT Services
have sold
to
a portfolio company of
Transaction details
Companyweb, the leading provider of subscription-based credit information and private company data intelligence in Belgium, has been sold to Altares, a provider of B2B data solutions, servicing medium and large companies across the entire data value chain
